Dr. Josh Rising is Pew’s director of health care programs, overseeing the medical device initiative and the improving end-of-life care project.
Before joining Pew, Rising helped establish the Office of Policy in the Food and Drug Administration’s Center for Tobacco Products. He also served as health policy analyst for the Connecticut Legislature, focusing on issues of health care access, Medicaid policy, health information technology, and health care quality. He also was legislative affairs director for the American Medical Student Association.
Rising received his medical degree and his master’s degree in public health from Boston University, completed his pediatric residency at the University of California, San Francisco, and trained for a year as a Robert Wood Johnson clinical scholar at Yale University.
Recent WorkView All
Patients rely on medical devices to replace failing joints, fix irregular heart rhythms, test blood sugar, diagnose diseases, and improve their health in other ways. While millions of people use these devices on a daily basis, researchers—including those in the federal government and at private organizations—lack an efficient way to track the performance of these products and quickly... Read More
On June 24, Pew submitted comments to the Centers for Medicare & Medicaid Services (CMS) about the agency’s proposed Merit-Based Incentive Payment System and Alternative Payment Models for eligible clinicians. In its comments, Pew encourages CMS to promote quality palliative and end-of-life care and encourages the collection and exchange of unique device identifier data to enhance... Read More
Under federal policies proposed in January, researchers, medical product innovators, and clinicians will gain unprecedented access to Medicare data that the Obama administration says will facilitate “smarter and more informed” health care decisions. Read More